• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂蛋白和红细胞在环孢素A于血液中的体外结合及分布中的作用。

Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood.

作者信息

Lemaire M, Tillement J P

出版信息

J Pharm Pharmacol. 1982 Nov;34(11):715-8. doi: 10.1111/j.2042-7158.1982.tb06206.x.

DOI:10.1111/j.2042-7158.1982.tb06206.x
PMID:6129301
Abstract

The distribution of cyclosporin A between plasma, leucocytes and erythrocytes was studied in vitro by means of sedimentation in Ficoll-Paque and dextran. The uptake by erythrocytes was found to be about 50% and the fraction of cyclosporin A bound to leucocytes amounted to 15%. Fractionation of plasma by ultracentrifugation also showed that two thirds of the drug were associated with lipoproteins whereas binding studies with isolated lipoproteins and plasma also indicated that lipoproteins were the major complexing constituents for cyclosporin A in plasma. The binding of cyclosporin A to erythrocytes and lipoproteins seems to be a linear process. The binding to the leucocytes may be a saturable process, however it is of minor importance in terms of the overall binding capacity in the blood.

摘要

通过在聚蔗糖-泛影葡胺和葡聚糖中沉降的方法,在体外研究了环孢素A在血浆、白细胞和红细胞之间的分布。发现红细胞的摄取量约为50%,与白细胞结合的环孢素A部分占15%。通过超速离心对血浆进行分级分离也表明,三分之二的药物与脂蛋白相关,而对分离的脂蛋白和血浆进行的结合研究也表明,脂蛋白是血浆中环孢素A的主要络合成分。环孢素A与红细胞和脂蛋白的结合似乎是一个线性过程。与白细胞的结合可能是一个可饱和的过程,然而就血液中的总体结合能力而言,它的重要性较小。

相似文献

1
Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood.脂蛋白和红细胞在环孢素A于血液中的体外结合及分布中的作用。
J Pharm Pharmacol. 1982 Nov;34(11):715-8. doi: 10.1111/j.2042-7158.1982.tb06206.x.
2
Distribution of cyclosporin G (NVa2 cyclosporin) in blood and plasma.环孢菌素G(NVa2环孢菌素)在血液和血浆中的分布。
Clin Chem. 1993 Feb;39(2):213-7.
3
Interaction of cyclosporin A with human lipoproteins.环孢素A与人脂蛋白的相互作用。
J Pharm Pharmacol. 1986 Aug;38(8):583-8. doi: 10.1111/j.2042-7158.1986.tb03085.x.
4
On the interaction of diazepam with human, rat and mouse plasma proteins and erythrocytes.关于地西泮与人、大鼠和小鼠血浆蛋白及红细胞的相互作用。
Biochem Pharmacol. 1982 Apr 1;31(7):1455-8. doi: 10.1016/0006-2952(82)90046-6.
5
Influence of blood components on the tissue uptake indices of cyclosporin in rats.血液成分对大鼠体内环孢素组织摄取指数的影响。
J Pharmacol Exp Ther. 1988 Feb;244(2):740-3.
6
Role of lipoproteins in the plasma binding of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin.脂蛋白在新型多药耐药逆转环孢素SDZ PSC 833血浆结合中的作用
Br J Clin Pharmacol. 1998 Feb;45(2):173-5. doi: 10.1046/j.1365-2125.1998.00663.x.
7
Binding of chlorpromazine, phenytoin and aspirin to the erythrocytes and lipoproteins in whole human blood.氯丙嗪、苯妥英和阿司匹林与全血中红细胞及脂蛋白的结合
J Pharm Pharmacol. 1987 Sep;39(9):740-2. doi: 10.1111/j.2042-7158.1987.tb06982.x.
8
Binding of indapamide to serum proteins and erythrocytes.吲达帕胺与血清蛋白及红细胞的结合
Biochem Pharmacol. 1988 Aug 1;37(15):2963-6. doi: 10.1016/0006-2952(88)90282-1.
9
Cyclosporin: erythrocyte binding and an examination of its use to estimate unbound concentration.环孢素:红细胞结合及其用于估计游离浓度的研究。
Ther Drug Monit. 1988;10(1):16-9.
10
Cyclosporin A and its metabolites, distribution in blood and tissues.环孢素A及其代谢产物在血液和组织中的分布。
J Int Med Res. 1991 Jan-Feb;19(1):1-18. doi: 10.1177/030006059101900101.

引用本文的文献

1
Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated F-fluorination of boroxines, in vitro and initial in vivo evaluation.作为OX1R选择性PET配体候选物的苏沃雷生杂芳基衍生物:硼酸酯的铜介导氟氟化、体外和初步体内评估
EJNMMI Res. 2024 Sep 4;14(1):80. doi: 10.1186/s13550-024-01141-2.
2
Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients.用于门诊肾移植受者中同时进行远程免疫抑制剂和肾功能监测的容量微采样。
Br J Clin Pharmacol. 2022 Nov;88(11):4854-4869. doi: 10.1111/bcp.15433. Epub 2022 Jun 17.
3
Physiologically-based pharmacokinetic model-based translation of OATP1B-mediated drug-drug interactions from coproporphyrin I to probe drugs.
基于生理的药代动力学模型将胆绿素 I 向探针药物的 OATP1B 介导的药物相互作用进行转化。
Clin Transl Sci. 2022 Jun;15(6):1519-1531. doi: 10.1111/cts.13272. Epub 2022 May 2.
4
Analysis of the variable factors affecting changes in the blood concentration of cyclosporine before and after transfusion of red blood cell concentrate.浓缩红细胞输注前后影响环孢素血药浓度变化的可变因素分析。
J Pharm Health Care Sci. 2022 Feb 1;8(1):4. doi: 10.1186/s40780-021-00235-6.
5
Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients.儿科肾移植受者维持性免疫抑制药物的治疗优化。
Expert Opin Drug Metab Toxicol. 2021 Jul;17(7):747-765. doi: 10.1080/17425255.2021.1943356. Epub 2021 Jun 29.
6
Comparing Predictions of a PBPK Model for Cyclosporine With Drug Levels From Therapeutic Drug Monitoring.将环孢素的生理药代动力学(PBPK)模型预测结果与治疗药物监测中的药物水平进行比较。
Front Pharmacol. 2021 May 14;12:630904. doi: 10.3389/fphar.2021.630904. eCollection 2021.
7
Analytical performance evaluation of the Elecsys® Cyclosporine and Elecsys® Tacrolimus assays on the cobas e411 analyzer.在 cobas e411 分析仪上对 Elecsys® 环孢素和 Elecsys® 他克莫司检测方法的分析性能评估。
Pract Lab Med. 2017 Mar 10;8:10-17. doi: 10.1016/j.plabm.2017.03.001. eCollection 2017 Aug.
8
PharmGKB summary: cyclosporine and tacrolimus pathways.药物基因组学知识库总结:环孢素和他克莫司途径。
Pharmacogenet Genomics. 2013 Oct;23(10):563-85. doi: 10.1097/FPC.0b013e328364db84.
9
Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.钙调磷酸酶抑制剂通过干扰 T 细胞辅助作用间接影响 B 细胞抗体应答。
Clin Exp Immunol. 2010 Feb;159(2):199-207. doi: 10.1111/j.1365-2249.2009.04051.x. Epub 2009 Nov 18.
10
Influence of overt diabetes mellitus on cyclosporine pharmacokinetics in a canine model.显性糖尿病对犬模型中环孢素药代动力学的影响。
Exp Diabetes Res. 2009;2009:363787. doi: 10.1155/2009/363787. Epub 2009 Oct 20.